Drug pipeline
Explore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The cysteinyl-leukotriene receptors (CysLTRs) are G protein–coupled receptors (GPCRs) that mediate the biological effects of cysteinyl leukotrienes (CysLTs), which are lipid mediators derived from arachidonic acid metabolism. There are two main subtypes: CysLT1R and CysLT2R, both of which play significant roles in inflammatory processes. Activation of these receptors leads to airway bronchoconstriction, increased vascular permeability and edema, recruitment of eosinophils and neutrophils, smooth muscle proliferation and fibrosis, and mucin secretion, contributing to the pathogenesis of asthma, allergic rhinitis, cardiovascular diseases, and potentially other conditions like certain cancers and CNS disorders.
CysLT1 receptor antagonism
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Cysteinyl-leukotriene Receptor (CysLTR).